Exploration of the therapeutic mechanism of Yiqi Jiedu recipe for treatment of primary liver cancer based on network pharmacology and molecular docking.
10.12122/j.issn.1673-4254.2022.06.03
- Author:
Meng XU
1
;
Peng ZHANG
2
;
Guo Liang ZHANG
3
Author Information
1. Graduate School of Anhui University of Chinese Medicine, Hefei 230038, China.
2. Department of General Surgery, First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
3. Department of Infection, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230038, China.
- Publication Type:Journal Article
- Keywords:
Yiqi Jiedu recipe;
molecular docking;
network pharmacology;
primary liver cancer
- MeSH:
DEAD-box RNA Helicases;
Drugs, Chinese Herbal/therapeutic use*;
Humans;
Liver Neoplasms/drug therapy*;
Molecular Docking Simulation;
Neoplasm Proteins;
Network Pharmacology;
Ribosomal Proteins;
Signal Transduction
- From:
Journal of Southern Medical University
2022;42(6):805-814
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the effective components of Yiqi Jiedu recipe and the main biological processes and signal pathways involved in the therapeutic mechanism of the recipe in treatment of primary liver cancer through network pharmacology and molecular docking approaches.
METHODS:TCMSP, Uniport, Genecards and String databases were searched to obtain the target genes of drugs and disease using Cytoscape 3.8.2 software. GO and KEGG enrichment analyses were performed to identify the common genes in the target genes of the drugs and disease. Using Pubcham, RCSB and Autoduck, the effective components of the drugs were connected with the final core genes. The effects of different concentrations of Yiqi Jiedu recipe on the expressions of the core genes DHX9, HNRNPK, NCL and PABPC1 in HepG2 cells were analyzed with Western blotting and real- time fluorescence quantitative PCR.
RESULTS:We finally identified 8 core genes from the drug and disease targets, including DDX5, HNRNPK, PABPC1, DHX9, RPS3A, RPS3, RPL13, and NCL. GO analysis showed that these core genes were involved mainly in the biological processes of adrenaline receptor signal communication, movement of cellular or subcellular components, blood particles, adhesion class and iron ion binding. KEGG analysis showed that the Ras signaling pathway had the greatest gene enrichment. The results of molecular docking suggested that the effective components of the recipe were capable of docking with the core genes under natural conditions, and PABPC1 and stigmasterol had the highest binding energy. In HepG2 cells, treatment with 10% medicated serum for 48 h had the strongest effect on the expression of DHX9, HNRNPK, NCL and PABPC1 (P < 0.05).
CONCLUSION:Yiqi Jiedu recipe is capable of regulating viral expression of primary liver cancer multiple effective components that bind to DHX9, HNRNPK, NCL and PABPC1.
